1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 23-valent Vaccine 1.2.3 10-valent Vaccine 1.2.4 7-valent Vaccine 1.2.5 13-valent Vaccine 1.3 Market by Application 1.3.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Child 1.3.3 Adult 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Perspective (2016-2027) 2.2 Pneumococcal Conjugate Vaccine (PCV) Growth Trends by Regions 2.2.1 Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pneumococcal Conjugate Vaccine (PCV) Historic Market Share by Regions (2016-2021) 2.2.3 Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Regions (2022-2027) 2.3 Pneumococcal Conjugate Vaccine (PCV) Industry Dynamic 2.3.1 Pneumococcal Conjugate Vaccine (PCV) Market Trends 2.3.2 Pneumococcal Conjugate Vaccine (PCV) Market Drivers 2.3.3 Pneumococcal Conjugate Vaccine (PCV) Market Challenges 2.3.4 Pneumococcal Conjugate Vaccine (PCV) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Revenue 3.1.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Revenue (2016-2021) 3.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Players (2016-2021) 3.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pneumococcal Conjugate Vaccine (PCV) Revenue 3.4 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio 3.4.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2020 3.5 Pneumococcal Conjugate Vaccine (PCV) Key Players Head office and Area Served 3.6 Key Players Pneumococcal Conjugate Vaccine (PCV) Product Solution and Service 3.7 Date of Enter into Pneumococcal Conjugate Vaccine (PCV) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pneumococcal Conjugate Vaccine (PCV) Breakdown Data by Type 4.1 Global Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Type (2016-2021) 4.2 Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Type (2022-2027) 5 Pneumococcal Conjugate Vaccine (PCV) Breakdown Data by Application 5.1 Global Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Application (2016-2021) 5.2 Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027) 6.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type 6.2.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) 6.2.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) 6.2.3 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027) 6.3 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application 6.3.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) 6.3.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) 6.3.3 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027) 6.4 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country 6.4.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) 6.4.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027) 7.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type 7.2.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) 7.2.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) 7.2.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027) 7.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application 7.3.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) 7.3.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) 7.3.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027) 7.4 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country 7.4.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) 7.4.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027) 8.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type 8.2.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027) 8.3 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application 8.3.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027) 8.4 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region 8.4.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027) 9.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type 9.2.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) 9.2.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) 9.2.3 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027) 9.3 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application 9.3.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) 9.3.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) 9.3.3 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027) 9.4 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country 9.4.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) 9.4.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size (2016-2027) 10.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type 10.2.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2027) 10.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application 10.3.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2027) 10.4 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country 10.4.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Introduction 11.1.4 Pfizer Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 GSK 11.2.1 GSK Company Details 11.2.2 GSK Business Overview 11.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Introduction 11.2.4 GSK Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) 11.2.5 GSK Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Introduction 11.3.4 Sanofi Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) 11.3.5 Sanofi Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Introduction 11.4.4 Merck Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) 11.4.5 Merck Recent Development 11.5 Walvax Biotechnology 11.5.1 Walvax Biotechnology Company Details 11.5.2 Walvax Biotechnology Business Overview 11.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Introduction 11.5.4 Walvax Biotechnology Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) 11.5.5 Walvax Biotechnology Recent Development 11.6 Royal (Wuxi) Bio-Pharmaceutical 11.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Details 11.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview 11.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Introduction 11.6.4 Royal (Wuxi) Bio-Pharmaceutical Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) 11.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development 11.7 Zhifei Biologic 11.7.1 Zhifei Biologic Company Details 11.7.2 Zhifei Biologic Business Overview 11.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Introduction 11.7.4 Zhifei Biologic Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) 11.7.5 Zhifei Biologic Recent Development 11.8 Serum Institute of India 11.8.1 Serum Institute of India Company Details 11.8.2 Serum Institute of India Business Overview 11.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Introduction 11.8.4 Serum Institute of India Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) 11.8.5 Serum Institute of India Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of 23-valent Vaccine Table 3. Key Players of 10-valent Vaccine Table 4. Key Players of 7-valent Vaccine Table 5. Key Players of 13-valent Vaccine Table 6. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions (2016-2021) Table 10. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions (2022-2027) Table 12. Pneumococcal Conjugate Vaccine (PCV) Market Trends Table 13. Pneumococcal Conjugate Vaccine (PCV) Market Drivers Table 14. Pneumococcal Conjugate Vaccine (PCV) Market Challenges Table 15. Pneumococcal Conjugate Vaccine (PCV) Market Restraints Table 16. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players (2016-2021) Table 18. Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2020) Table 19. Ranking of Global Top Pneumococcal Conjugate Vaccine (PCV) Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Pneumococcal Conjugate Vaccine (PCV) Product Solution and Service Table 23. Date of Enter into Pneumococcal Conjugate Vaccine (PCV) Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million) Table 26. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2016-2021) Table 27. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Application (2016-2021) Table 31. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million) Table 34. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million) Table 36. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2022-2027) & (US$ Million) Table 63. Pfizer Company Details Table 64. Pfizer Business Overview Table 65. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Table 66. Pfizer Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million) Table 67. Pfizer Recent Development Table 68. GSK Company Details Table 69. GSK Business Overview Table 70. GSK Pneumococcal Conjugate Vaccine (PCV) Product Table 71. GSK Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million) Table 72. GSK Recent Development Table 73. Sanofi Company Details Table 74. Sanofi Business Overview Table 75. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Table 76. Sanofi Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million) Table 77. Sanofi Recent Development Table 78. Merck Company Details Table 79. Merck Business Overview Table 80. Merck Pneumococcal Conjugate Vaccine (PCV) Product Table 81. Merck Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million) Table 82. Merck Recent Development Table 83. Walvax Biotechnology Company Details Table 84. Walvax Biotechnology Business Overview Table 85. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Table 86. Walvax Biotechnology Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million) Table 87. Walvax Biotechnology Recent Development Table 88. Royal (Wuxi) Bio-Pharmaceutical Company Details Table 89. Royal (Wuxi) Bio-Pharmaceutical Business Overview Table 90. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Table 91. Royal (Wuxi) Bio-Pharmaceutical Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million) Table 92. Royal (Wuxi) Bio-Pharmaceutical Recent Development Table 93. Zhifei Biologic Company Details Table 94. Zhifei Biologic Business Overview Table 95. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Table 96. Zhifei Biologic Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million) Table 97. Zhifei Biologic Recent Development Table 98. Serum Institute of India Company Details Table 99. Serum Institute of India Business Overview Table 100. Serum Institute of India Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) & (US$ Million) Table 101. Serum Institute of India Recent Development Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Type: 2020 VS 2027 Figure 2. 23-valent Vaccine Features Figure 3. 10-valent Vaccine Features Figure 4. 7-valent Vaccine Features Figure 5. 13-valent Vaccine Features Figure 6. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application: 2020 VS 2027 Figure 7. Child Case Studies Figure 8. Adult Case Studies Figure 9. Pneumococcal Conjugate Vaccine (PCV) Report Years Considered Figure 10. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions: 2020 VS 2027 Figure 13. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Regions (2022-2027) Figure 14. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players in 2020 Figure 15. Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2020 Figure 17. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2016-2021) Figure 18. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2022-2027) Figure 19. North America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027) Figure 21. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027) Figure 22. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2016-2027) Figure 23. United States Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027) Figure 27. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027) Figure 28. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2016-2027) Figure 29. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027) Figure 37. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027) Figure 38. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Share by Region (2016-2027) Figure 39. China Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027) Figure 47. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027) Figure 48. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2016-2027) Figure 49. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Share by Type (2016-2027) Figure 53. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2016-2027) Figure 54. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2016-2027) Figure 55. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Pfizer Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) Figure 59. GSK Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) Figure 60. Sanofi Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) Figure 61. Merck Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) Figure 62. Walvax Biotechnology Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) Figure 63. Royal (Wuxi) Bio-Pharmaceutical Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) Figure 64. Zhifei Biologic Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) Figure 65. Serum Institute of India Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Pfizer GSK Sanofi Merck Walvax Biotechnology Royal (Wuxi) Bio-Pharmaceutical Zhifei Biologic Serum Institute of India